Kymera Therapeutics (KYMR) Total Liabilities (Quarterly): 152.74M

Kymera Therapeutics, Inc. (KYMR)

131.73 +3.61 (+2.82%) USD | NASDAQ | Nov 06, 16:00

131.70 -0.03 (-0.02%) After-Hours: 20:00

Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2019. Start Trial.

Date	Value
September 30, 2026	152.74M
June 30, 2026	136.19M
March 31, 2026	129.38M
December 31, 2025	163.15M
September 30, 2025	155.79M
June 30, 2025	159.59M
March 31, 2025	132.08M
December 31, 2024	142.42M
September 30, 2024	141.91M
June 30, 2024	141.10M
March 31, 2024	157.05M
December 31, 2023	180.79M
September 30, 2023	156.84M
June 30, 2023	146.52M

Date	Value
March 31, 2023	151.90M
December 31, 2022	112.98M
September 30, 2022	125.59M
June 30, 2022	125.47M
March 31, 2022	134.34M
December 31, 2021	146.27M
September 30, 2021	159.32M
June 30, 2021	176.28M
March 31, 2021	189.30M
December 31, 2020	203.29M
September 30, 2020	212.68M
June 30, 2020	77.07M
March 31, 2020
December 31, 2019	82.03M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks